Industry News (Joint Venture)

Collaboration on Gene Function Determination Announced

Published in Gene Therapy Weekly, June 10th, 1996

Ribozyme Pharmaceuticals, Inc. (RPI), Boulder, Colorado, and Chiron Corp., Emeryville, California, announced a collaboration to use RPI's ribozyme technology to probe the function of a number of gene sequences.

Under the collaboration, Chiron selects gene sequences and RPI designs and synthesizes ribozymes that selectively inhibit the action of the target sequences in Chiron's assays. Chiron has the option to develop ribozymes or other products against sequences found to be important in disease pathology. RPI receives research support, milestone payments, royalties and ribozyme manufacturing rights on products resulting from the collaboration.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1996-06-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry